Health Canada approves Biocon Biologics’ YESAFILI, first EYLEA biosimilar, for launch in July 2025 EP News Bureau Jun 27, 2025 YESAFILI becomes Biocon Biologics’ tenth biosimilar to be commercialised globally, with Canada as the first launch market
